Parkside Financial Bank & Trust’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-25
| Closed | -$94 | – | 2074 |
|
|
2023
Q3 | $94 | Sell |
25
-245
| -91% | -$921 | ﹤0.01% | 2031 |
|
|
2023
Q2 | $1.15K | Buy |
270
+249
| +1,186% | +$1.06K | ﹤0.01% | 1814 |
|
|
2023
Q1 | $144 | Sell |
21
-64
| -75% | -$439 | ﹤0.01% | 1975 |
|
|
2022
Q4 | $673 | Sell |
85
-102
| -55% | -$808 | ﹤0.01% | 1876 |
|
|
2022
Q3 | $2K | Buy |
187
+37
| +25% | +$396 | ﹤0.01% | 1512 |
|
|
2022
Q2 | $1K | Sell |
150
-48
| -24% | -$320 | ﹤0.01% | 1687 |
|
|
2022
Q1 | $3K | Sell |
198
-18
| -8% | -$273 | ﹤0.01% | 1468 |
|
|
2021
Q4 | $3K | Buy |
216
+2
| +0.9% | +$28 | ﹤0.01% | 1477 |
|
|
2021
Q3 | $3K | Buy |
214
+7
| +3% | +$98 | ﹤0.01% | 1418 |
|
|
2021
Q2 | $3K | Buy |
207
+40
| +24% | +$580 | ﹤0.01% | 1404 |
|
|
2021
Q1 | $2K | Hold |
167
| – | – | ﹤0.01% | 1472 |
|
|
2020
Q4 | $3K | Buy |
167
+107
| +178% | +$1.92K | ﹤0.01% | 1277 |
|
|
2020
Q3 | $1K | Buy |
+60
| New | +$1K | ﹤0.01% | 1300 |
|